Works by Shahir, Ashwin

Results: 7

Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breast cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231151840

By:

Paluch-Shimon, Shani;
Neven, Patrick;
Huober, Jens;
Cicin, Irfan;
Goetz, Matthew P.;
Shimizu, Chikako;
Huang, Chiun-Sheng;
Lueck, Hans Joachim;
Beith, Jane;
Tokunaga, Eriko;
Contreras, Jessica Reyes;
de Sant'Ana, Rosane Oliveira;
Wei, Ran;
Shahir, Ashwin;
Nabinger, Sarah C.;
Forrester, Tammy;
Johnston, Stephen R. D.;
Harbeck, Nadia

Publication type:

Article

Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors.

Published in:

Cancer Medicine, 2021, v. 10, n. 3, p. 843, doi. 10.1002/cam4.3658

By:

Mascarenhas, Leo;
Ogawa, Chitose;
Laetsch, Theodore W.;
Weigel, Brenda J.;
Bishop, Michael W.;
Krystal, Julie;
Borinstein, Scott C.;
Slotkin, Emily K.;
Muscal, Jodi A.;
Hingorani, Pooja;
Levy, Donna E.;
Mo, Gary;
Shahir, Ashwin;
Wright, Jennifer;
DuBois, Steven G.

Publication type:

Article

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma.

Published in:

Cancer Medicine, 2020, v. 9, n. 3, p. 882, doi. 10.1002/cam4.2728

By:

Villalobos, Victor M.;
Mo, Gary;
Agulnik, Mark;
Pollack, Seth M.;
Rushing, Daniel A.;
Singh, Arun;
Van Tine, Brian A.;
McNaughton, Rhian;
Decker, Rodney L.;
Zhang, Wei;
Shahir, Ashwin;
Cronier, Damien M.

Publication type:

Article

Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.

Published in:

NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00639-1

By:

Goetz, Matthew P.;
Cicin, Irfan;
Testa, Laura;
Tolaney, Sara M.;
Huober, Jens;
Guarneri, Valentina;
Johnston, Stephen R. D.;
Martin, Miguel;
Rastogi, Priya;
Harbeck, Nadia;
Shahir, Ashwin;
Wei, Ran;
André, Valérie;
Rugo, Hope S.;
O'Shaughnessy, Joyce

Publication type:

Article

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.

Published in:

2020

By:

Tap, William D.;
Wagner, Andrew J.;
Schöffski, Patrick;
Martin-Broto, Javier;
Krarup-Hansen, Anders;
Ganjoo, Kristen N.;
Yen, Chueh-Chuan;
Abdul Razak, Albiruni R.;
Spira, Alexander;
Kawai, Akira;
Le Cesne, Axel;
Van Tine, Brian A.;
Naito, Yoichi;
Park, Se Hoon;
Fedenko, Alexander;
Pápai, Zsuzsanna;
Soldatenkova, Victoria;
Shahir, Ashwin;
Mo, Gary;
Wright, Jennifer

Publication type:

journal article

Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer.

Published in:

2018

By:

McGuire, William P;
Penson, Richard T;
Gore, Martin;
Herraez, Antonio Casado;
Peterson, Patrick;
Shahir, Ashwin;
Ilaria, Robert Jr

Publication type:

journal article

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer.

Published in:

Investigational New Drugs, 2018, v. 36, n. 4, p. 629, doi. 10.1007/s10637-017-0532-2

By:

Goldman, Jonathan W.;
Rosen, Lee S.;
Tolcher, Anthony W.;
Papadopoulos, Kyriakos;
Beeram, Muralidhar;
Shi, Peipei;
Pitou, Celine;
Bell, Robert;
Kulanthaivel, Palaniappan;
Zhang, Xuekui;
Fink, Aaron;
Chan, Edward M.;
Shahir, Ashwin;
Farrington, Daphne;
Patnaik, Amita

Publication type:

Article